Literature DB >> 32485273

Environmental contamination of SARS-CoV-2 during the COVID-19 outbreak in South Korea.

Byung-Han Ryu1, Younghwa Cho2, Oh-Hyun Cho1, Sun In Hong1, Sunjoo Kim3, Seungjun Lee4.   

Abstract

OBJECTIVES: Although contact precaution is generally recommended in situations where coronavirus disease 2019 (COVID-19) is suspected, there is limited evidence on environmental contamination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, we conducted environmental surveillance on SARS-CoV-2 contamination in 2 different healthcare settings.
METHODS: Viral contamination was investigated on the environment of 2 hospitals that had admitted 13 COVID-19 patients. In hospital A, 5 patients with pneumonia occupied negative pressure rooms. In hospital B, 8 asymptomatic patients shared 2 common 4-bed rooms. Most rooms were poorly cleaned or disinfected. Environmental swab were collected from inside and outside the rooms and were tested using real-time RT-PCR for the detection of SARS-CoV-2.
RESULTS: In hospital A, SARS-CoV-2 was detected in 10 of 57 (17.5%) samples from inside the rooms including the Ambu bag and infusion pump. Two samples obtained at more than 2 m from the patients showed positive results. In hospital B, 3 of 22 (13.6%) samples from inside the rooms were positive. Areas outside the rooms, such as the anteroom, corridor, and nursing station, were all negative in both hospitals.
CONCLUSIONS: Hospital surfaces surrounding patients were contaminated by SARS-CoV-2. Our findings support the value of strict contact precaution, routine cleaning, and disinfection in the management of COVID-19 patients.
Copyright © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contact precaution; Infection control; Novel coronavirus; Surface contamination

Mesh:

Year:  2020        PMID: 32485273      PMCID: PMC7260524          DOI: 10.1016/j.ajic.2020.05.027

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that had not been previously reported, is the causative pathogen of coronavirus disease 2019 (COVID-19), originating from Wuhan, China. Since the first report of COVID-19 in December 2019, this viral respiratory syndrome has spread very rapidly, and the threat of a pandemic has become a reality. Epidemiological studies have demonstrated that human-to-human transmission is the important route of these massive outbreaks. Nosocomial outbreaks of this highly contagious respiratory virus could have a huge impact on public health because there is a risk of collapsing the medical system if healthcare workers (HCWs) become infected. In data from the Chinese Center for Disease Control and Prevention, 1,716 of 44,672 confirmed cases (3.8%) were HCWs. In addition, in a study conducted in Wuhan, HCWs accounted for 40 out of 138 patients (29%). In this regard, appropriate infection control guidelines are essential for the prevention of nosocomial transmission of SARS-CoV-2 to HCWs. Close contact with SARS-CoV-2-contaminated surfaces is thought to be one of the possible routes of transmission. Thus, the World Health Organization recommends contact precaution in situations where COVID-19 is suspected. However, our predictions of the contagious nature of SARS-CoV-2 are largely based on past experiences with other human coronaviruses,7, 8, 9 and there are still undiscovered aspects regarding the transmission pattern of this novel coronavirus. Therefore, we investigated the environmental contamination of SARS-CoV-2 in different settings of hospitals that admitted patients with various severities.

Methods

Patients and rooms

In March 2020, 13 confirmed COVID-19 patients were admitted to hospitals A and B in Changwon, South Korea. Hospital A had 5 patients, and 2 of them (patients 1 and 2) were in negative pressure isolation rooms located in the intensive care unit (ICU). Patient 1 had severe pneumonia (defined as fever or suspected respiratory infection plus 1 of the following: respiratory rate >30/min, severe respiratory distress, or SpO2 ≤93% on room air) and received mechanical ventilator care and vasopressor infusion. Patient 2, who complained of increasing dyspnea, also had severe pneumonia and received oxygen via a nasal prong. The remaining 3 patients (patients 3-5) occupied negative pressure rooms in the isolation ward. Patients 3 and 4 had severe pneumonia, and oxygen was supplied via high-flow nasal cannula (HFNC). Patients 1-4 were classified in the high-risk group according to the NEWS scoring system. Patient 5 had mild pneumonia (defined as no signs of severe pneumonia plus no need for supplemental oxygen) without specific symptoms (initial symptoms were resolved at the time of environmental sampling). All isolation rooms in hospital A had anterooms and met the detailed standard for installation and operation of the negative pressure isolation room enacted by the Ministry of Health and Welfare, South Korea. In hospital B, 8 asymptomatic patients (patients 6-13, their initial symptoms were already resolved at the time of environmental sampling) with a stable clinical course were admitted to 2 common 4-bed rooms without negative pressure and ventilation systems because the South Korean government decided to collectively accommodate patients with only mild symptoms due to the lack of negative pressure rooms during the massive epidemic of COVID-19. The beds were placed at 2-m distances in the 4 corners of the room and were divided by curtains. All rooms in hospital B were connected directly to a common corridor without anterooms. Additional information on the patients and rooms is presented in Table 1 .
Table 1

Patient and room data at the time of environmental sampling

HospitalPatient numberPatient statusPatient data
Room data
Clinical syndromeRespiratory symptomMask-wearing behaviorDays from
SiteVentilation with negative pressureHours from the last room disinfection
Symptom onsetLast (+) RT-PCR
A1Mechanical ventilation with vasopressorSevere pneumoniaN/AN/A1214*ICUYes32
2Nasal cannulaSevere pneumoniaDyspneaCoughGood101ICUYes23
3HFNCSevere pneumoniaDyspneaBad31WardYes24
4HFNCSevere pneumoniaDyspneaCoughBad92WardYes1
5Nasal cannulaMild pneumoniaNoGood181WardYes72
B6Room airN-SNoGood1414WardNo184
7Room airMild pneumoniaNoGood171
8Room airN-SNoGood1616
9Room airN-SNoGood1313
10Room airN-SNoGood3811WardNo184
11Room airN-SNoGood2613
12Room airN-SNoGood181
13Room airN-SNoGood1613

Abbreviations: HFNC, high-flow nasal cannula; ICU, intensive care unit; N/A, not available; N-S, nonspecific.

Given the strong epidemiologic relationship between a COVID-19 outbreak cluster and patient 1, a PCR test was performed before symptom onset.

Good mask-wearing behavior means wearing a mask to cover nose, mouth, and chin.

Bad mask-wearing behavior means that the nose, mouth, and chin are not completely covered.

Patient and room data at the time of environmental sampling Abbreviations: HFNC, high-flow nasal cannula; ICU, intensive care unit; N/A, not available; N-S, nonspecific. Given the strong epidemiologic relationship between a COVID-19 outbreak cluster and patient 1, a PCR test was performed before symptom onset. Good mask-wearing behavior means wearing a mask to cover nose, mouth, and chin. Bad mask-wearing behavior means that the nose, mouth, and chin are not completely covered.

Environmental sampling

Environmental samples were collected from each patient's room and ancillary spaces, such as the anteroom, adjacent common corridor, and nursing station. Dacron swabs premoistened with viral transport medium (Copan Italia SpA, Brescia, Italy) were used to swab environmental surfaces aseptically. The swabbed surfaces included the following: (1) patient room (ie, patient monitor, ventilator monitor, HFNC, blood pressure cuff, pillow, suction bottle and line, Ambu bag, infusion pump, wall oxygen supply, fluid stand, door button or knob, bed side rail, head and foot of the bed, nurse call controller, lower part of the window frame, top of the television [TV], air exhaust damper, wall and floor of the room, toilet paper holder, and inside and seat of the toilet); (2) the anteroom (ie, door button, keyboard, mouse, and floor); (3) the floor of an adjacent common corridor; and (4) the nursing station (ie, counter, interphone, keyboard, mouse, chair, and floor). The standard cleaning procedures of the isolation rooms used 0.1% hypochlorite solution. However, due to the shortage of personal protective equipment (PPE) and vague fears of cleaners, room cleaning, and disinfection were not performed every day. This study was approved by the Institutional Review Board of Gyeongsang National University Changwon Hospital (GNUCH NON2020-0001).

Laboratory procedures

Virus RNA was extracted from environmental swab samples using an ExiPrep 48 Viral DNA/RNA Kit (Bioneer, Daejeon, Korea) and ExiPrep 48 Dx (Bioneer) according to the manufacturer's instructions. Real-time RT-PCR was performed using an Allplex 2019-nCoV Assay (Seegene, Seoul, Korea) and a CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA). The Allplex 2019-nCoV Assay, a multiplex real-time PCR assay, detects the SARS-CoV-2 E gene, RdRp gene, and N gene. When all 3 genes showed positive findings, we interpreted the case as positive. When positive findings were found for 1 or 2 genes, we regarded the case as presumptive positive.

Results

Hospital A (more severe patients in well-equipped isolation rooms)

In hospital A, SARS-CoV-2 RNA was detected in 10 of 57 (17.5%) environmental samples inside the rooms using real-time RT-PCR. Among those, 6 of 10 (60%) environmental samples obtained from the ICU isolation room occupied by patient 1 were positive. All 3 target genes were detected on the Ambu bag and infusion pump. Two of the target genes were detected on the pillow and patient monitor, and one was detected on the ceiling air exhaust damper (Fig 1 ). From the rooms of patients 3 and 4, 2 environmental samples each were found to be contaminated with SARS-CoV-2 genes (fluid stand and head of the bed: 2 of 3 genes; top of the TV and patient monitor: 1 of 3 genes). The rooms of patients 2 and 5 were negative by real-time RT-PCR. No viral RNA was detected outside the isolation rooms – in the anteroom, corridor, and nursing station – of hospital A.
Fig 1

Illustration of the ICU negative pressure isolation room occupied by patient 1. The black circles indicate positivity for all 3 SARS-CoV-2 target genes (= positive). The dark gray circles and light gray circles indicate positive results for 2 and 1 of 3 target genes (= presumptive positive), respectively.

Illustration of the ICU negative pressure isolation room occupied by patient 1. The black circles indicate positivity for all 3 SARS-CoV-2 target genes (= positive). The dark gray circles and light gray circles indicate positive results for 2 and 1 of 3 target genes (= presumptive positive), respectively.

Hospital B (less severe patients in common hospital rooms)

Three of 22 (13.6%) environmental samples inside hospital B's rooms were positive for SARS-CoV-2 genes by real-time RT-PCR. The room floor center and toilet seat were found to be positive for all 3 target genes. One target gene was detected on the side rail of a bed. Other objects, such as doorknobs of patient rooms and restrooms, common corridors, and nursing stations, were all negative (Fig 2 ). Table 2 and Appendix Table 1 present details of the real-time RT-PCR results.
Fig 2

Floor plan of hospital B. Eight asymptomatic COVID-19 patients shared 2 common 4-bed rooms. The black circles indicate positivity for all 3 target SARS-CoV-2 genes (floor center and toilet seat). The light gray circle indicates presumptive positive for 1 of 3 target genes (side rail of patient 12’s bed).

Table 2

Real-time RT-PCR results of environmental sampling

HospitalPatient numberInside the roomOutside the room
Number of real-time RT-PCR-positive samples (collected surface)
AnteroomCorridorNursing station3 of 3 target genes2 of 3 target genes1 of 3 target genes
A16/100/1*N/AN/A2Ambu bagInfusion pump3PillowBed side railPatient monitor1Air exhaust damper
20/100/2N/AN/A000
32/120/20/10/301Fluid stand1Upper part of TV
42/130/20/101Head of the bed1Patient monitor
50/120/1*0/1000
B6-91/11N/A0/10/51Center of room floor00
10-132/11N/A0/10/51Seat of toilet01Side rail of patient 12’s bed

Abbreviations: N/A, not available; TV, television.

One sample with invalid results was excluded from the results.

The isolation rooms of patients 3-5 share the same nursing station.

Floor plan of hospital B. Eight asymptomatic COVID-19 patients shared 2 common 4-bed rooms. The black circles indicate positivity for all 3 target SARS-CoV-2 genes (floor center and toilet seat). The light gray circle indicates presumptive positive for 1 of 3 target genes (side rail of patient 12’s bed). Real-time RT-PCR results of environmental sampling Abbreviations: N/A, not available; TV, television. One sample with invalid results was excluded from the results. The isolation rooms of patients 3-5 share the same nursing station.

Discussion

Our results clearly show environmental contamination of the COVID-19 patients’ surroundings by SARS-CoV-2. Indeed, viruses have been found on various hospital objects, and these surfaces can be sources of nosocomial transmission via direct contact. Therefore, our findings provide an important basis for justification of strict contact precaution. Compared to the other rooms occupied by “milder” patients, the ICU isolation room of the most severe patient (patient 1 with severe pneumonia who received frequent suction during mechanical ventilation) was more severely contaminated. Viral RNA was detected in 6 of 10 samples (60%) collected from the room, which was a significantly higher contamination rate than those of the 2 common rooms shared by 8 asymptomatic patients (9.1%-18.2%) as well as the 3 isolation rooms of other patients with severe pneumonia (0%-16.7%). Substantial viral dispersion by frequent oral/endotracheal suction could be responsible for this extensive contamination of surrounding environmental surfaces. It was somewhat surprising that the viral detection rates of the rooms of the 3 severe pneumonia patients other than patient 1 were not as high as expected. The patients’ symptoms, wearing a mask, and cleaning/disinfection of room may have been associated with this finding. Patient 2 coughed intermittently but wore a dental mask most of the time; patient 3 had no symptoms other than dyspnea; and patient 4 coughed frequently, did not use a dental mask properly, and had the lowest cycle threshold values (Ct value of 14.48 for the E gene) of the real-time RT-PCR for the respiratory specimen among all the patients (Supplementary Table 1). However, the room of patient 4 was the only place where samples were collected immediately after cleaning/disinfection. Additionally, unique viral kinetics of SARS-CoV-2 – the highest viral load is present during the early phase of infection, and a reduction in viral load occurs at the beginning of pneumonia progression – may also partly support our finding. The outbreak at a shopping mall in Wenzhou, China, showed indirect clues of airborne transmission of SARS-CoV-2. According to a report from Singapore, SARS-CoV-2 was found in air outlet fans of a hospital room. In our study, environmental samples from an air exhaust damper in patient 1’s room and from the top of the TV in patient 3’s room showed “presumptive positive” results. The former is located in the ceiling, and the latter was located more than 2 m from the patient. These findings suggest the possibility of aerosolization of the virus. However, the following arguments may rise against our assessment: (1) frequent respiratory tract manipulation, such as oral/endotracheal suction, produced aerosols, but the chance that strong negative pressure pulled them up to the ceiling exhaust damper cannot be ruled out; (2) the high gas flow of HFNC may trigger aerosol production, although a recently published study showed that HFNC was not associated with increased aerosolization; and (3) patient 3 was able to move, although HFNC might have been uncomfortable, and the TV was at an easily accessible height. Therefore, the relationship between aerosols and the SARS-CoV-2 transmission mode cannot be explained by our observations. Further studies are needed to solve this issue. However, as seen in the precedent of SARS-CoV or MERS-CoV, it would be safe to follow airborne precautions until additional data are available, especially for patients at high risk of aerosol production. Our study has several limitations. First, actual infectivity by live SARS-CoV-2 was not evaluated using viral cultures. Second, air sampling could not be performed due to the absence of equipment. For this reason, we could not investigate the presence of aerosolized viral particles in ambient air. Third, patients in the early stages of the illness were not sufficiently included, and most of the patients were considered as mid-to-late stage. Fourth, environmental samplings were conducted at different single timepoints for each patient, not periodically collected according to the course of the illness. In conclusion, there was SARS-CoV-2 contamination of the hospital environment. Strict contact precaution, routine cleaning, and disinfection are mandatory in the management of patients infected with SARS-CoV-2.
  14 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-02-10

3.  Evidence of airborne transmission of the severe acute respiratory syndrome virus.

Authors:  Ignatius T S Yu; Yuguo Li; Tze Wai Wong; Wilson Tam; Andy T Chan; Joseph H W Lee; Dennis Y C Leung; Tommy Ho
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

4.  Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020.

Authors:  Jing Cai; Wenjie Sun; Jianping Huang; Michelle Gamber; Jing Wu; Guiqing He
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

5.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 6.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Authors:  G Kampf; D Todt; S Pfaender; E Steinmann
Journal:  J Hosp Infect       Date:  2020-02-06       Impact factor: 3.926

Review 7.  Severe acute respiratory syndrome.

Authors:  Michael D Christian; Susan M Poutanen; Mona R Loutfy; Matthew P Muller; Donald E Low
Journal:  Clin Infect Dis       Date:  2004-04-29       Impact factor: 9.079

8.  A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).

Authors:  Ying-Hui Jin; Lin Cai; Zhen-Shun Cheng; Hong Cheng; Tong Deng; Yi-Pin Fan; Cheng Fang; Di Huang; Lu-Qi Huang; Qiao Huang; Yong Han; Bo Hu; Fen Hu; Bing-Hui Li; Yi-Rong Li; Ke Liang; Li-Kai Lin; Li-Sha Luo; Jing Ma; Lin-Lu Ma; Zhi-Yong Peng; Yun-Bao Pan; Zhen-Yu Pan; Xue-Qun Ren; Hui-Min Sun; Ying Wang; Yun-Yun Wang; Hong Weng; Chao-Jie Wei; Dong-Fang Wu; Jian Xia; Yong Xiong; Hai-Bo Xu; Xiao-Mei Yao; Yu-Feng Yuan; Tai-Sheng Ye; Xiao-Chun Zhang; Ying-Wen Zhang; Yin-Gao Zhang; Hua-Min Zhang; Yan Zhao; Ming-Juan Zhao; Hao Zi; Xian-Tao Zeng; Yong-Yan Wang; Xing-Huan Wang
Journal:  Mil Med Res       Date:  2020-02-06

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.

Authors:  Jin Yong Kim; Jae Hoon Ko; Yeonjae Kim; Yae Jean Kim; Jeong Min Kim; Yoon Seok Chung; Heui Man Kim; Myung Guk Han; So Yeon Kim; Bum Sik Chin
Journal:  J Korean Med Sci       Date:  2020-02-24       Impact factor: 2.153

View more
  25 in total

1.  Infectious Aerosol Capture Mask as Environmental Control to Reduce Spread of Respiratory Viral Particles.

Authors:  Joshua L Santarpia; Nicholas W Markin; Vicki L Herrera; Daniel N Ackerman; Danielle N Rivera; Gabriel A Lucero; Steven J Lisco
Journal:  Viruses       Date:  2022-06-11       Impact factor: 5.818

Review 2.  The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop?

Authors:  Hooi-Leng Ser; Vengadesh Letchumanan; Bey-Hing Goh; Sunny Hei Wong; Learn-Han Lee
Journal:  Front Microbiol       Date:  2021-05-13       Impact factor: 5.640

3.  Containing COVID-19 outside the isolation ward: The impact of an infection control bundle on environmental contamination and transmission in a cohorted general ward.

Authors:  Liang En Ian Wee; Xiang Ying Jean Sim; Edwin Philip Conceicao; May Kyawt Aung; Kwee Yuen Tan; Kwan Ki Karrie Ko; Hei Man Wong; Limin Wijaya; Ban Hock Tan; Indumathi Venkatachalam; Moi Lin Ling
Journal:  Am J Infect Control       Date:  2020-06-26       Impact factor: 2.918

4.  Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Authors:  Nicola Giesen; Rosanne Sprute; Maria Rüthrich; Yascha Khodamoradi; Sibylle C Mellinghoff; Gernot Beutel; Catherina Lueck; Michael Koldehoff; Marcus Hentrich; Michael Sandherr; Michael von Bergwelt-Baildon; Hans-Heinrich Wolf; Hans H Hirsch; Bernhard Wörmann; Oliver A Cornely; Philipp Köhler; Enrico Schalk; Marie von Lilienfeld-Toal
Journal:  Eur J Cancer       Date:  2020-09-21       Impact factor: 9.162

Review 5.  An updated min-review on environmental route of the SARS-CoV-2 transmission.

Authors:  Edris Hoseinzadeh; Mahdi Farzadkia; Farshid Mohammadi; Hooshyar Hossini; Mahmoud Taghavi
Journal:  Ecotoxicol Environ Saf       Date:  2020-07-09       Impact factor: 6.291

6.  SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy.

Authors:  Katia Razzini; Marta Castrica; Laura Menchetti; Lorenzo Maggi; Lucia Negroni; Nicola V Orfeo; Alice Pizzoccheri; Matteo Stocco; Stefano Muttini; Claudia M Balzaretti
Journal:  Sci Total Environ       Date:  2020-06-26       Impact factor: 10.753

Review 7.  Immune Response and COVID-19: A mirror image of Sepsis.

Authors:  Eduardo López-Collazo; José Avendaño-Ortiz; Alejandro Martín-Quirós; Luis A Aguirre
Journal:  Int J Biol Sci       Date:  2020-07-09       Impact factor: 6.580

Review 8.  Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2.

Authors:  G Kampf; Y Brüggemann; H E J Kaba; J Steinmann; S Pfaender; S Scheithauer; E Steinmann
Journal:  J Hosp Infect       Date:  2020-09-18       Impact factor: 3.926

Review 9.  Current understanding of the surface contamination and contact transmission of SARS-CoV-2 in healthcare settings.

Authors:  Hosoon Choi; Piyali Chatterjee; John D Coppin; Julie A Martel; Munok Hwang; Chetan Jinadatha; Virender K Sharma
Journal:  Environ Chem Lett       Date:  2021-02-11       Impact factor: 9.027

Review 10.  Environmental and decontamination issues for human coronaviruses and their potential surrogates.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-07-02       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.